Eisai Co Ltd (EII) Stock Price & News

Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia

About Eisai Co Ltd

CEOHaruo Naito | Haruo Naito

Employees10.9K

FoundedDec 6, 1941

HeadquartersBunkyo City, Tokyo, Japan

SectorPharmaceutical industry

Websiteeisai.co.jp

All values in JPY	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	202.65B	197.36B	219.94B	205.43B
Cost of goods sold	42.60B	45.52B	51.08B	52.01B
Cost of revenue	42.60B	45.52B	51.08B	52.01B
Research and development expenses	38.79B	36.74B	39.20B	42.90B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	99.97B	104.06B	111.72B	112.04B
Operating expense	139.11B	138.36B	148.82B	155.20B
Total operating expenses	181.71B	183.88B	199.90B	207.21B
Operating income	20.94B	13.48B	20.03B	-1.78B
Other non operating income	1.00M	1.00M	-1.00M	-3.00M
EBT including unusual items	22.40B	14.53B	22.00B	-7.94B
EBT excluding unusual items	22.60B	14.34B	22.00B	591.00M
Income tax expense	7.07B	4.00B	4.16B	-4.75B
Effective tax rate	31.55%	27.51%	18.90%	59.77%
Other operating expenses	353.00M	-2.44B	-2.10B	250.00M
Net income	14.47B	10.16B	17.18B	-3.25B
Net profit margin	7.14%	5.15%	7.81%	-1.58%
Earnings per share	-	-	-	-
Interest and investment income	2.58B	2.30B	3.40B	3.92B
Interest expense	-916.00M	-1.44B	-1.43B	-1.55B
Net interest expenses	1.66B	856.00M	1.97B	2.38B
Depreciation and amortization charges	-	-	-	-
EBITDA	30.64B	23.29B	30.10B	8.20B
Gain or loss from assets sale	-	1.31B	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research